Professional Documents
Culture Documents
Aminoglycoside ND Macrolide
Aminoglycoside ND Macrolide
Aminoglycoside ND Macrolide
AMINOGLYCOSIDES
treatment of serious infections due to aerobic gram-
negative bacilli associated with serious toxicities replaced by safer antibiotics: 3rd and 4th generation Cephalosporins Fluoroquinolones Carbapenems
derived from:
STREPTOMYCES *-mycin e.g. Neomycin Streptomycin Tobramycin
Streptomycetaceae largest antibiotic-producing genus gram positive characterized by a complex secondary metabolism
AMINOCYCLITOL two amino sugars joined by a glycosidic linkage to a central hexose nucleus polycationic nature: easy passage across tissue membranes
MECHANISM OF ACTION
gram negative: diffuse through porin channels in outer membrane * oxygen- dependent and transport drug across cytoplasmic membrane binds to 30S ribosomal subunit interrupt process of polysome disaggregation and assembly
Antibacterial Spectrum treatment of infections caused by Pseudomonas aeruginosa for aerobic organisms reason: anaerobes lack oxygen- requiring drug transport system synergistic effect: beta-lactams and vancomycin bactericidal lethality: bacteriostatic
Resistance decreased uptake of drug when uptake of oxygendependent transport system is absent plasmid- associated synthesis of enzymes * modify and inactivate aminoglycosides cross-resistance: invariable
Pharmacokinetics A. Administration
highly polar and polycationic: prevent absorption route: parenteral * adequate serum levels bactericidal effect: concentration and time dependent have postantibiotic effect fewer toxicities less expensive
B. Distribution low tissue levels variable penetration in most body fluids CSF concentrations are inadequate administered intrathecally or intraventricularly cross the placental barrier accumulate in fetal plasma and amniotic fluid C. Metabolism excreted into urine by GFR accumulation with renal failure patients * dose modification
Adverse Effects *Peak levels: 30 mins-1 hr after infusion *Trough levels: immediately before the next dose (OD) *Factors triggering AE: a. Old age b. Previous exposure to aminoglycosides c. Liver disease
MACROLIDES / KETOLIDES
MACROLIDES
Mechanism of Action irreversibly bind to a site on 50S subunit of bacterial ribosome interfere transpeptidation bacteriostatic bactericidal at higher doses binding site: identical
Antibacterial Spectrum 1. Erythromycin -same as penicillin G -allergic to penicillin 2. Clarithromycin -effective against Hemophilus infuenzae -higher activity against intracellular pathogens e.g. Chlamydia, Legionella, Moraxella, Ureaplasma, Helicobacter pylori 3. Azithromycin -less active against streptococci and staphylococci
- H. influenzae and Moraxella catarrhalis -Chlamydia trachomatis: urethritis -Mycobacterium avium-intracellulare: AIDS and disseminated infections 4. Telithromycin -neutralize resistance mechanisms e.g. methylase-mediated; efflux-mediated Resistance inability to take up the antibiotic or efflux pump decreased affinity of 50S subunit presence of plasmid-associated erythromycin esterase
Pharmacokinetics
Erythromycin destroyed by gastric acid readily absorbed ETC and esterified forms food interferes absorption absorbed upon oral administration distribute well except CNS diffuse to prostatic fluid accumulate in macrophages metabolize and inhibit through CYP450 excreted in bile partial reabsorption Clarithromycin stable in stomach readily absorbed food interaction increase widely distributed in tissues oxidized to 14hydroxy derivative eliminated in kidney and liver Azithromycin destroyed by gastric acid readily absorbed food interferes absorption IV widely distributed in tissues low serum levels longest half-life largest Vd excreted in bile
Telithromycin
Adverse Effects GI Disturbances Cholestatic Jaundice- hypersensitivity reaction to estolate form (Erythromycin) Ototoxicity
Contraindications with hepatic dysfunction- accumulate in liver Telithromycin hepatoxicity with congenital prolongation of QTc interval with proarrythmic conditions with myasthenia gravis